Atlas FDA

GEN-PROBE(R) AMPLIFIED MYCOBACTERIUM TUBERCULOSIS DIRECT TEST (MTD TEST)

FDA premarket approval P940034/S005 · decided 1998-01-07

Approval details

PMA number
P940034
Supplement
S005
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
GEN-PROBE(R) AMPLIFIED MYCOBACTERIUM TUBERCULOSIS DIRECT TEST (MTD TEST)
Generic name
System, nucleic acid amplification, mycobacterium tuberculosis complex
Applicant
Gen-Probe, Inc.
Date received
1997-07-02
Decision date
1998-01-07
Days to decision
189 days
Decision code
APPR
Product code
MWA
Advisory committee
Microbiology
Expedited review
No
Location
San Diego, CA
Statement
Approval for Physician Prescribing Information to be considered a component of the labeling for MTD. At this time there are no provisions for "in vitro" device labeling other than prescribed 21 CFR 809.10 (b); however, the Physician Prescribing Information may be used as promotional and advertising material.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
APTIMA TRICHOMONAS VAGINALIS ASSAY - PANTHER (K122062)Gen-Probe, Inc.2013-01-09
APTIMA COMBO 2 ASSAY (K111409)Gen-Probe, Inc.2012-05-03
GEN-PROBE APTIMA ASSAY FOR NEISSERIA GONORRHOEAE MODEL#1091 (K063664)Gen-Probe, Inc.2007-01-25
GEN-PROBE APTIMA ASSAY FOR CHLAMYDIA TRACHOMATIS, MODEL 1199 (K063451)Gen-Probe, Inc.2007-01-22
GEN-PROBE APTIMA ASSAY FOR NEISSERIA GONORRHOEAE, MODEL 1091 (K062440)Gen-Probe, Inc.2006-11-07
APTIMA CT ASSAY ON THE TIGRIS DTS SYSTEM (K061413)Gen-Probe, Inc.2006-10-13
TIGRIS DTS GEN-PROBE APTIMA ASSAY FOR NEISSERIA GONORRHOEAE, MODEL 1196 (K061509)Gen-Probe, Inc.2006-10-04
TIGRIS DTS GEN-PROBE APTIMA COMBO 2 ASSAY (K060652)Gen-Probe, Inc.2006-08-17